BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

782 related articles for article (PubMed ID: 10333911)

  • 1. Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes.
    Meneilly GS; Elliott T
    Diabetes Care; 1999 Jan; 22(1):112-8. PubMed ID: 10333911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NIDDM in the elderly.
    Meneilly GS; Elliott T; Tessier D; Hards L; Tildesley H
    Diabetes Care; 1996 Dec; 19(12):1320-5. PubMed ID: 8941457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alterations in glucose metabolism in the elderly patient with diabetes.
    Meneilly GS; Dawson K; Tessier D
    Diabetes Care; 1993 Sep; 16(9):1241-8. PubMed ID: 8404427
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological importance of first-phase insulin release in elderly patients with diabetes.
    Meneilly GS; Elahi D
    Diabetes Care; 1998 Aug; 21(8):1326-9. PubMed ID: 9702442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between hepatic/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects.
    Gastaldelli A; Cusi K; Pettiti M; Hardies J; Miyazaki Y; Berria R; Buzzigoli E; Sironi AM; Cersosimo E; Ferrannini E; Defronzo RA
    Gastroenterology; 2007 Aug; 133(2):496-506. PubMed ID: 17681171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations in non-insulin-mediated glucose uptake in the elderly patient with diabetes.
    Forbes A; Elliott T; Tildesley H; Finegood D; Meneilly GS
    Diabetes; 1998 Dec; 47(12):1915-9. PubMed ID: 9836524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contribution of obesity to defects of intracellular glucose metabolism in NIDDM.
    Chung JW; Suh KI; Joyce M; Ditzler T; Henry RR
    Diabetes Care; 1995 May; 18(5):666-73. PubMed ID: 8586004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.
    Mari A; Pacini G; Murphy E; Ludvik B; Nolan JJ
    Diabetes Care; 2001 Mar; 24(3):539-48. PubMed ID: 11289482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glucose disposal in obese non-diabetic and diabetic type II patients. A study by indirect calorimetry and euglycemic insulin clamp.
    Golay A; Defronzo RA; Thorin D; Jequier E; Felber JP
    Diabete Metab; 1988; 14(4):443-51. PubMed ID: 3066652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-mediated glucose disposal in insulin-resistant normoglycemic relatives of type 2 diabetic patients.
    Henriksen JE; Levin K; Thye-Rønn P; Alford F; Hother-Nielsen O; Holst JJ; Beck-Nielsen H
    Diabetes; 2000 Jul; 49(7):1209-18. PubMed ID: 10909980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glucagon-like peptide-1 (7-37) augments insulin-mediated glucose uptake in elderly patients with diabetes.
    Meneilly GS; McIntosh CH; Pederson RA; Habener JF; Gingerich R; Egan JM; Elahi D
    J Gerontol A Biol Sci Med Sci; 2001 Nov; 56(11):M681-5. PubMed ID: 11682575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic effects of troglitazone therapy in type 2 diabetic, obese, and lean normal subjects.
    Frias JP; Yu JG; Kruszynska YT; Olefsky JM
    Diabetes Care; 2000 Jan; 23(1):64-9. PubMed ID: 10857970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo glucose metabolism in obese and type II diabetic subjects with or without hypertension.
    Bonora E; Bonadonna RC; Del Prato S; Gulli G; Solini A; Matsuda M; DeFronzo RA
    Diabetes; 1993 May; 42(5):764-72. PubMed ID: 8482434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of hyperglycemia on insulin's in vivo effects in type II diabetes.
    Revers RR; Fink R; Griffin J; Olefsky JM; Kolterman OG
    J Clin Invest; 1984 Mar; 73(3):664-72. PubMed ID: 6368585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contribution of obesity to insulin resistance in noninsulin-dependent diabetes mellitus.
    Perriello G; Misericordia P; Volpi E; Pampanelli S; Santeusanio F; Brunetti P; Bolli GB
    J Clin Endocrinol Metab; 1995 Aug; 80(8):2464-9. PubMed ID: 7629243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of lipid oxidation in pathogenesis of insulin resistance of obesity and type II diabetes.
    Felber JP; Ferrannini E; Golay A; Meyer HU; Theibaud D; Curchod B; Maeder E; Jequier E; DeFronzo RA
    Diabetes; 1987 Nov; 36(11):1341-50. PubMed ID: 3311856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin secretion in normal glucose-tolerant relatives of type 2 diabetic subjects. Assessments using hyperglycemic glucose clamps and oral glucose tolerance tests.
    van Haeften TW; Dubbeldam S; Zonderland ML; Erkelens DW
    Diabetes Care; 1998 Feb; 21(2):278-82. PubMed ID: 9539996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-mediated increase in blood flow is impaired in the elderly.
    Meneilly GS; Elliot T; Bryer-Ash M; Floras JS
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1899-903. PubMed ID: 7775638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of obesity on insulin resistance in normal subjects and patients with NIDDM.
    Ludvik B; Nolan JJ; Baloga J; Sacks D; Olefsky J
    Diabetes; 1995 Sep; 44(9):1121-5. PubMed ID: 7657038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.